₹-0.08
(Market cap
₹40 Cr
Recently Viewed
Clear AllMarket cap
₹40 Cr
Revenue (TTM)
₹21 Cr
P/E Ratio
50.6
P/B Ratio
1.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹1 Cr
ROE
1.8 %
ROCE
3.2 %
Industry P/E
34.01
EV/EBITDA
17.3
Debt to Equity
0.2
Book Value
₹11.6
EPS
₹0.4
Face value
10
Shares outstanding
19,998,476
CFO
₹9.69 Cr
EBITDA
₹1.28 Cr
Net Profit
₹3.33 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Veerhealth Care
| 4.2 | 0.7 | 13.2 | 39.8 | 24.8 | 35.0 | 10.4 |
|
BSE Healthcare
| 2.9 | 4.5 | 8.1 | 6.7 | 25.3 | 14.0 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Veerhealth Care
| -5.3 | -7.8 | 76.1 | 85.2 | 58.2 | -15.6 | 0.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Veerhealth Care
|
20.2 | 40.3 | 21.3 | 0.8 | 1.7 | 3.5 | 50.6 | 1.7 |
| 1,045.0 | 12,831.5 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.6 | 4.1 | |
| 443.7 | 7,697.5 | 1,053.1 | 293.6 | 32.3 | 24.6 | 26.2 | 5.9 | |
| 1,057.9 | 11,062.6 | 1,158.7 | 309.6 | 31.9 | 17.3 | 35.4 | 5.8 | |
| 1,638.0 | 31,022.5 | 8,850.1 | 894.8 | 15.2 | 19.8 | 35.7 | 6.2 | |
| 358.5 | 3,884.1 | 159.3 | 47.8 | 39.0 | 18.6 | 81.3 | 14.0 | |
| 14,755.0 | 18,930.5 | 1,575.1 | 179.1 | 14.9 | 11.4 | 105.7 | 11.4 | |
| 2,011.8 | 3,324.1 | 673.7 | 202.6 | 17.6 | 19.4 | 16.4 | 5.8 | |
| 939.8 | 4,320.3 | 588.5 | 102.9 | 22.1 | 12.7 | 42.5 | 5.1 | |
| 211.6 | 5,579.0 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.4 |
No Review & Analysis are available.
Veerhealth Care Limited manufactures and markets ayurvedic medicines in India. The company also offers tablets, syrups, ointments, powders, oils, shampoos, cosmetics, and toothpastes. It also exports its products. The company was formerly known as... Niyati Industries Limited and changed its name to Veerhealth Care Limited in September 2013. Veerhealth Care Limited was incorporated in 1992 and is headquartered in Mumbai, India. Read more
Incorporated
1992
Chairman
Yogesh M Shah
Managing Director
Bhavin S Shah
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Veerhealth Care Ltd is ₹20.15 (BSE) as of 27-Apr-2026 IST. Veerhealth Care Ltd has given a return of 24.77% in the last 3 years.
The P/E ratio of Veerhealth Care Ltd is 50.62 times as on 27-Apr-2026, a 49 premium to its peers’ median range of 34.01 times.
The P/B ratio of Veerhealth Care Ltd is 1.74 times as on 27-Apr-2026, a 23 discount to its peers’ median range of 2.27 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.54
|
1.10
|
|
2024
|
102.21
|
1.90
|
|
2023
|
6.34
|
0.94
|
|
2022
|
0.00
|
0.57
|
|
2021
|
13.90
|
0.38
|
The 52-week high and low of Veerhealth Care Ltd are Rs 23.77 and Rs 11.81 as of 27-Apr-2026.
Veerhealth Care Ltd has a market capitalisation of ₹ 40 Cr as on 27-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Veerhealth Care Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.